| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02098469 |
| P698 | PubMed publication ID | 8307050 |
| P50 | author | Fernando Cabanillas | Q44062466 |
| P2093 | author name string | G Bodey | |
| W Lo | |||
| E Whimbey | |||
| L Elting | |||
| R Couch | |||
| P2860 | cites work | Effect of cancer chemotherapy on the immune response to influenza virus vaccine: review of published studies | Q39833197 |
| Influenza immunization of children with neoplastic diseases | Q40862981 | ||
| Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients | Q42927446 | ||
| Immunization with influenza vaccine in patients with haematological malignant disease | Q44951658 | ||
| Reactogenicity and Immunogenicity of Bivalent Influenza Vaccine in One- and Two-Dose Trials in Children: A Summary | Q45056829 | ||
| Influenza vaccination in elderly residents in nursing homes: immune response to trivalent and monovalent inactivated influenza virus vaccine in the season 1986-87. | Q45843196 | ||
| Responses of patients with neoplastic diseases to influenza virus vaccine | Q45889412 | ||
| Antibody Response in Hodgkin's Disease and Other Lymphomas Related to HL-A Antigens, Immunoglobulin Levels and Therapy | Q47955526 | ||
| Influenza immunization of adult patients with malignant diseases | Q50948355 | ||
| The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine | Q67467316 | ||
| Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly | Q67540229 | ||
| Influenza: its control in persons and populations | Q70018779 | ||
| Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q72334654 | ||
| The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission | Q93820571 | ||
| P433 | issue | 10 | |
| P921 | main subject | influenza vaccine | Q383260 |
| chemotherapy | Q974135 | ||
| adult lymphoma | Q18557022 | ||
| P304 | page(s) | 778-782 | |
| P577 | publication date | 1993-10-01 | |
| P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
| P1476 | title | Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy | |
| P478 | volume | 12 |
| Q33950824 | A comparison of cytomegalovirus and community respiratory viruses in immunocompromised patients |
| Q45734876 | Association between cancer chemotherapy and canine distemper virus, canine parvovirus, and rabies virus antibody titers in tumor-bearing dogs |
| Q45731339 | Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae |
| Q40410633 | Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients |
| Q33950850 | Community respiratory viral infections in the immunocompromised host: past, present, and future directions |
| Q33950804 | Community respiratory virus infections in immunocompromised patients with cancer |
| Q33404690 | De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination |
| Q34146495 | Efficacy of the influenza vaccine in patients with malignant lymphoma |
| Q43175183 | Epidemiology and outcomes of hospitalization of influenza in the cancer population in Taiwan |
| Q43490574 | Epidemiology and outcomes of serious influenza-related infections in the cancer population |
| Q40685571 | Epidemiology of Influenza A virus infection in patients with acute or chronic leukemia |
| Q35018548 | Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients |
| Q35705166 | Immunogenicity of an Inactivated Monovalent 2009 Influenza A (H1N1) Vaccine in Patients Who Have Cancer |
| Q40154337 | Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial |
| Q33950831 | Infection control of nosocomial respiratory viral disease in the immunocompromised host |
| Q28079486 | Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety |
| Q37416103 | Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses |
| Q50927965 | Influenza vaccination following liver transplantation in children |
| Q28740919 | Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective |
| Q27027645 | Influenza vaccination in cancer patients undergoing systemic therapy |
| Q37251090 | Influenza vaccination in hematopoietic SCT recipients |
| Q24202869 | Influenza vaccines in immunosuppressed adults with cancer |
| Q49500210 | Influenza vaccines in immunosuppressed adults with cancer |
| Q30385118 | Influenza vaccines: from surveillance through production to protection. |
| Q86272533 | Modeling Dendritic Cell Vaccination for Influenza Prophylaxis: Potential Applications for Niche Populations |
| Q30421416 | Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemi |
| Q36388960 | Practical review of immunizations in adult patients with cancer |
| Q30305790 | Prevention and treatment of influenza in immunocompromised patients |
| Q30395200 | Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host |
| Q42094332 | Report on influenza A and B viruses: their coinfection in a Saudi leukemia patient |
| Q35270361 | Response to influenza immunisation during treatment for cancer |
| Q42258618 | Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours |
| Q30403660 | The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies |
| Q24533456 | Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host |
| Q26829398 | Vaccination recommendations for the hematology and oncology and post-stem cell transplant populations |
| Q24235812 | Vaccines for prophylaxis of viral infections in patients with hematological malignancies |
| Q24245832 | Vaccines for prophylaxis of viral infections in patients with hematological malignancies |
| Q39118448 | Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation |
Search more.